Study of an experimental drug for lung cancer with fluid in the chest
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have non-small cell lung cancer that has spread to the lining of the chest, causing fluid buildup.
- You have trouble breathing because of the fluid.
- You have not had any local treatment in your chest, like drugs or radiation, in the past month.
- You are generally able to care for yourself (ECOG score 0-2) and expected to live at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JMKX000197 against a standard chemotherapy drug (cisplatin) to see which is better at reducing fluid buildup around the lungs in people with advanced cancer. The goal is to ease breathing and improve quality of life.
This trial tests an investigational drug called JMKX000197 given into the chest to control fluid buildup caused by cancer. It is for people with advanced solid tumors that have led to a moderate or large pleural effusion requiring drainage.
This study collects fluid that builds up around your lungs (pleural effusion) during a drainage procedure you already need. Researchers test how different drugs affect your cancer cells in the lab to help predict which treatments might work best for you.
This trial tests whether adding a traditional Chinese medicine called Xuan Yin Ning to an existing drug (bevacizumab) can help control fluid buildup around the lung in people with advanced non-small cell lung cancer. The goal is to reduce symptoms like shortness of breath and improve quality of life.
This study tests whether a thin, flexible tube (like a small camera) can safely and effectively help doctors get tissue samples from fluid around the lung. It compares a single-use flexible tool to a standard semi-rigid scope, and may help find the cause of your lung fluid.
This trial tests a new drug called MT027 for people with advanced cancer that has spread to the lining around the lungs (pleura) and caused fluid buildup. The drug targets a marker on cancer cells called B7-H3. It may help control the fluid and the cancer.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.